Oxidative stress and non-enzymatic glycation in IgA nephropathy

Clinical Nephrology

Volumn 64, Issue 5, 2005, Pages 343-351

  Vas, T ^a   Wagner, Z ^a   Jenei, V ^c   Varga, Z ^c   Kovacs T ^a   Wittmann, I ^a   Schinzel, R ^b   Balla, G ^c   Balla, J ^c   Heidland, A ^b   Nagy, Judit ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Glycation end products; IgA nephropathy; Oxidative stress

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; FLUORESCENCE ANALYSIS; GLYCATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DYSFUNCTION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL;

EID: 27944463137     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp64343     Document Type: Article

References (50)

1. American Diabetes Association 2004 Diagnosis and classification of diabetes mellitus. Diabetes Care 27 (Suppl 1): S5-S10
2. Balla J, Belcher JD, Balla G, Jacob HS, Vercellotti GM 1993 Oxidized low-density lipoproteins and endothelium: oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury. Trans Assoc Am Physicians 106: 128-133
3. Bayes B, Pastor MC, Bonal J, Junca J, Hernandez JM, Riutort N, Foraster A, Romero R 2003 Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant 18: 106-112
4. Baynes JW, Thorpe SR 1999 Role of oxidative stress in diabetic complications. Diabetes 48: 1-9
5. Brownlee M 1995 Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223-234
6. Chan JCM, Mahan JD, Trachtman H, Scheinman J, Flynn JT, Alon US, Lande MB, Weiss RA, Norkus RP 2003 Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study. Pediatr Nephrol 18: 1015-1019
7. Chen A, Chen WP, Shen LF, Lin CY 1994 Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complexes. J Pathol 173: 119-126
8. Cockroft DW, Gault MH 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
9. Devasena T, Lalitha S, Padma K 2001 Lipid peroxidation, osmotic fragility and antioxidant status in children with acute post-streptococcal glomerulonephritis. Clin Chim Acta 308: 155-161
10. Dolhofer-Bliesener R, Lechner B, Deppisch R, Ritz E, Gerbitz KD 1995 Immunological determination of advanced glycosilation end-products in human blood and urine. Nephrol Dial Transplant 10: 657-664
11. Drueke TB, Nguyen-Khoa T, Massy ZA, Witko-Sarsat V, Lacour B, Descamps-Latscha B 2001 Role of oxidized low-density lipoprotein in the atherosclerosis of uraemia. Kidney Int 78: 114-119
12. Fliser D, Pacini G, Engeletter R, Kautzky-Willer A, Prager R, Franek E, Ritz E 1998 Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 53: 1343-1347
13. Floege J, Feehally J 2000 IgA nephropathy: recent developments. J Am Soc Nephrol 11: 2395-2403
14. Fornasieri A, Perugini C, Seccia M, Napodano P, D'Amico G, Bellomo G 2002 Circulating antibodies recognising oxidatively modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis. J Nephrol 15: 349-357
15. Galli F, Canestrari F, Bellomo G 1999 Physiopathology of the oxidative stress and its implication in uremia and hemodialysis in vitamin E-bonded membrane. A further step in dialysis optimization. In: Ronco C, La Geca G (eds) Contribution to Nephrology. Karger, Basel, pp 1-31
16. Galli F, Varga Zs, Balla J, Ferraro B, Canestrari F, Floridi A, Kakuk G, Buoncristiani U 2001 Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 59 (Suppl 78): S148-S154
17. Gwinner W, Gröne H 2000 Role of reactive oxygen species in glomerulonephritis. Nephrol Dial Transplant 15: 1127-1132
18. Halliwell B, Guttridge JM 1999 Free radicals in biology and medicine (3rd ed). University Press, Oxford
19. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G 2002 Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887
20. Jentzsch AM, Bachmann H, Fürst P, Biesalski HK 1996 Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med 20: 251-256
21. Julian BA 2001 IgA nephropathy and related disorders. In: Greenberg A (ed) Primer on Kidney Diseases (3rd ed). Academic Press, San Diego, pp 165-171
22. Kashem A, Endoh M, Nomoto Y, Sakai H, Nakazawa H 1994 FcαR expression on polymorphonuclear leukocyte and superoxide generation in IgA nephropathy. Kidney Int 45: 868-875
23. Kashem A, Endoh M, Yano M, Yamauchi F, Nomoto Y, Sakai H, Pronai L, Tanaka M, Nakazawa H 1997 Glomerular FcαR expression and disease activity in IgA nephropathy. Am J Kidney Dis 30: 389-396
24. Kato Y, Hayaski M, Ohno Y, Suzawa T, Sasaki T, Sarurta T 2000 Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. Clin Nephrol 54: 366-373
25. Koroliczuk A, Chibowski D, Beltowski J, Wojcicka G 2001 Selected markers of oxidative stress in rats with active Heymann nephritis. Med Sci Monit 7: 369-376
26. Kuemmerle NB, Krieg RJ, Chan W, Trachtman H, Norkus EP, Chan JCM 1999 Influence of α-tocopherol over the time course of experimental IgA nephropathy. Pediatr Nephrol 13: 108-112
27. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C 2003 Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 18: 1272-1280
28. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G 1994 Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 46: 869-876
29. Mak SK, Wong PN, Lo KY, Tong GM, Wong AK 2001 Prospective study on renal outcome of IgA nephropathy superimposed on diabetic glomerulosclerosis in type 2 diabetic patients. Nephrol Dial Transplant 16: 1183-1188
30. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, van Ypersele de Strihou C, Kurokawa K 1998 Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 53: 416-422
31. Nishimura H, Sanaka T, Nihei H, Nishikawa M, Aikawa E 1996 Mechanism of elevated local oxidant stress in early anti-glomerular basement membrane nephritis: an evaluation of oxidant production and superoxide dismutase expression. Nippon Jinzo Gakkai Shi 38: 441-448
32. Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawno K, Tsukada Y 1998 Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res Clin Pract 41: 131-137
33. Ruperez FJ, Barbas C, Castro M, Martiney S, Herrera E 1998 Simplified method for vitamin E determination in rat adipose tissue and mammary glands by high-performance liquid chromatography. J Chromatogr A 823: 483-487
34. Schinzel R, Münch G, Heidland A 2001 Advanced glycation end products in end-stage renal disease and their removal. Nephron 87: 295-303
35. Schleicher ED, Wagner E, Nerlich AG 1997 Increased accumulation of the glycoxidation product Nε-(carboxymethyl)-lysine in human tissues in diabetes and aging. J Clin Invest 99: 457-468
36. Serban MG, Tanaseanu S, Bara C 1996 Oxidant stress and antioxidant protection in lupus nephropathy. Rom J Intern Med 34: 105-109
37. Sugiyama S, Miyata T, Ueda Y, Tanaka H, Maeda K, Kawashima S, van Ypersele de Strihou C, Korokawa K 1998 Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol 9: 1681-1688
38. Sutherland WH, Walker RJ, Ball MJ, Stapley SA, Robertson MC 1995 Oxidation of low-density lipoproteins from patients with renal failure or renal transplants. Kidney Int 48: 227-236
39. Trachtman H, Chan JCM, Chan W, Walderrama E, Brandt R, Wakely P, Futterweit S, Maesaka J, Ma C 1996 Vitamin E ameliorates renal injury in an experimental model of immunglobulin A nephropathy. Pediatr Res 40: 620-626
40. Tsuruoka S, Kawaguchi A, Nishiki K, Hayasaka T, Fukushima C, Sugimoto K, Saito T, Fujimura A 2002 Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure. Am J Kidney Dis 39: 127-133
41. Túri S, Németh I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J 1997 Oxidative stress and antioxidant defense mechanism in glomerular diseases. Free Radic Biol Med 22: 161-168
42. Ujhelyi L, Balla J, Muszbek L, Kakuk G, Belcher J, Jacob HS, Vercelotti GM, Balla G 1998 A microassay to assess the oxidative resistance of low-density lipoproteins. Clin Chem 44: 1762-1764
43. Usberti M, Gerardi GM, Gazzotti RM, Benedini S, Archetti S, Sugherini L, Valentini M, Tira P, Bufano G, Albertini A, Di Lorenzo D 2002 Oxidative stress and cardiovascular disease in dialyzed patients. Nephron 91: 25-33
44. van Tits L, de Graaf J, Hak-Lemmers H, Bredie S, Demacker P, Holvoet P, Stalenhoef A 2003 Increased levels of low-density lipoprotein oxidation in patients with familiar hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Invest 83: 13-21
45. Varga Zs, Kárpáti I, Paragh Gy, Buris L, Kakuk Gy 1997 Relative abundance of some free fatty acids in plasma of uremic patients: relationship between fatty acids, lipid parameters, and diseases. Nephron 77: 417-421
46. Wagner Z, Wittmann I, Mazák I, Schinzel R, Heidland A, Kientsch-Engel R, Nagy J 2001 Nε-(carboxymethyl)-lysine levels in type 2 diabetic patients: role of renal function. Am J Kidney Dis 38: 785-791
47. Wardle EN 2000 Oxidative processes in glomerulonephritides: additional facts. Review. Nephron 85: 103-106
48. Westhuyzen J, Saltissi D, Healy H 1997 Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls. Atherosclerosis 129: 199-205
49. Westwood ME, Thornalley PJ 1997 Glycation and advanced glycation endproducts. In: Colaco C (ed) The Glycation Hypothesis of Atherosclerosis. Landes Bioscience, Austin, Texas, USA, pp 57-87
50. Witko-Sarsat V, Nguyen Khoa T, Jungers P, Drueke TB, Descamps-Latscha B 1999 Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 14 (Suppl 1): S76-S78